In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal.
Cantiello, F., Russo, G.I., Vartolomei, M.D., Farhan, A.R.A., Terracciano, D., Musi, G., et al. (2018). Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer. EUROPEAN UROLOGY ONCOLOGY, 1(5), 403-410 [10.1016/j.euo.2018.06.006].
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer
Serretta, VincenzoMembro del Collaboration Group
;Verze, Paolo;BATTAGLIA, Michele;
2018-01-01
Abstract
In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal.
| File | Dimensione | Formato | |
|---|---|---|---|
|
EUROPEAN UROLOGY ONCOLOGY 2018.pdf
Solo gestori archvio
Dimensione
835.48 kB
Formato
Adobe PDF
|
835.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
